Cumberland 4Q profit falls on higher costs

Wed, 03/10/2010 - 7:17am
The Associated Press

Cumberland Pharmaceuticals said Wednesday its fourth-quarter profit fell on higher operating expenses and interest costs tied to the company's credit facility.

The company earned $300,000, or a penny per share, compared with $1.1 million, or 7 cents per share, a year prior. Revenue rose 9 percent to $10.7 million from $9.8 million.

Analysts polled by Thomson Reuters expected a penny per share profit on revenue of $11.5 million.

Operating expenses rose 20 percent to $10 million, mainly for sales and marketing costs as the company launched the injectable ibuprofen Caldolor.

For the full year, the company earned $3.1 million, or 17 cents per share, compared with profit of $4.8 million, or 29 cents per share, in 2008. Revenue rose 24 percent to $43.5 million.

Shares of Cumberland Pharmaceuticals Inc. fell 18 cents to $11.82 in morning trading.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.